关注
Parham Jabbarzadeh Kaboli (ORCID: 0000-0002-4157-7901)
Parham Jabbarzadeh Kaboli (ORCID: 0000-0002-4157-7901)
PhD (Pharmacology, UPM, Malaysia), Postdoc (China Medical University, Taiwan)
在 mail.cmu.edu.tw 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer
P Jabbarzadeh Kaboli, A Rahmat, P Ismail, KH Ling
European Journal of Pharmacology 740, 584-595, 2014
1382014
MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment
PJ Kaboli, A Rahmat, P Ismail, KH Ling
Pharmacological research 97, 104-121, 2015
1212015
m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer
Y Zhao, Q Zhao, PJ Kaboli, J Shen, M Li, X Wu, J Yin, H Zhang, Y Wu, ...
Translational oncology 12 (10), 1323-1333, 2019
582019
An ethnobotanical survey of medicinal plants used by indigenous people in Zangelanlo district, Northeast Iran
SA Mohammad, J Parham, A Mahdi
Journal of Medicinal Plants Research 6 (5), 749-753, 2012
572012
Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer–A comprehensive review from chemotherapy to immunotherapy
PJ Kaboli, F Salimian, S Aghapour, S Xiang, Q Zhao, M Li, X Wu, F Du, ...
Pharmacological research 156, 104806, 2020
552020
Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study
P Jabbarzadeh Kaboli, MPY Leong, P Ismail, KH Ling
Pharmacological Reports 71 (1), 13-23, 2019
342019
Engineered TCR-T cell immunotherapy in anticancer precision medicine: pros and cons
Q Zhao, Y Jiang, S Xiang, PJ Kaboli, J Shen, Y Zhao, X Wu, F Du, M Li, ...
Frontiers in Immunology 12, 658753, 2021
262021
Conditional reprogramming: next generation cell culture
X Wu, S Wang, M Li, J Li, J Shen, Y Zhao, J Pang, Q Wen, M Chen, B Wei, ...
Acta Pharmaceutica Sinica B 10 (8), 1360-1381, 2020
242020
CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells
J Yin, H Zhang, X Wu, Y Zhang, J Li, J Shen, Y Zhao, Z Xiao, L Lu, ...
International journal of molecular medicine 45 (6), 1783-1792, 2020
232020
Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer–contradictory effects and future perspectives
PJ Kaboli, MA Khoshkbejari, M Mohammadi, A Abiri, R Mokhtarian, ...
Biomedicine & Pharmacotherapy 121, 109635, 2020
232020
Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy
Y Wu, J Li, PJ Kaboli, J Shen, X Wu, Y Zhao, H Ji, F Du, Y Zhou, Y Wang, ...
Pharmacological research 155, 104691, 2020
212020
Characterization of chemical composition and prebiotic effect of a dietary medicinal plant Penthorum chinense Pursh
J Yin, W Ren, B Wei, H Huang, M Li, X Wu, A Wang, Z Xiao, J Shen, ...
Food chemistry 319, 126568, 2020
202020
m5C RNA Methylation Primarily Affects the ErbB and PI3K–Akt Signaling Pathways in Gastrointestinal Cancer
S Xiang, Y Ma, J Shen, Y Zhao, X Wu, M Li, X Yang, PJ Kaboli, F Du, H Ji, ...
Frontiers in molecular biosciences 7, 599340, 2020
192020
A review of Penthorum chinense Pursh for hepatoprotection: traditional use, phytochemistry, pharmacology, toxicology and clinical trials
A Wang, M Li, H Huang, Z Xiao, J Shen, Y Zhao, J Yin, PJ Kaboli, J Cao, ...
Journal of ethnopharmacology 251, 112569, 2020
192020
Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: a new group of RAF inhibitors for cancer treatment
P Jabbarzadeh Kaboli, P Ismail, KH Ling
PLoS One 13 (3), e0193941, 2018
192018
Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets
D Li, S Xiang, J Shen, M Xiao, Y Zhao, X Wu, F Du, H Ji, M Li, Q Zhao, ...
International journal of biological sciences 16 (4), 568, 2020
172020
Long non-coding RNAs: potential biomarkers and targets for hepatocellular carcinoma therapy and diagnosis
D Yuan, Y Chen, X Li, J Li, Y Zhao, J Shen, F Du, PJ Kaboli, M Li, X Wu, ...
International Journal of Biological Sciences 17 (1), 220, 2021
122021
Molecular markers of regulatory T cells in cancer immunotherapy with special focus on acute myeloid leukemia (AML)-a systematic review
PJ Kaboli, L Zhang, S Xiang, J Shen, M Li, Y Zhao, X Wu, Q Zhao, ...
Current Medicinal Chemistry 27 (28), 4673-4698, 2020
122020
Identification of prognostic genes in the tumor microenvironment of hepatocellular carcinoma
S Xiang, J Li, J Shen, Y Zhao, X Wu, M Li, X Yang, PJ Kaboli, F Du, ...
Frontiers in Immunology 12, 653836, 2021
112021
Analysis of key genes regulating the warburg effect in patients with gastrointestinal cancers and selective inhibition of this metabolic pathway in liver cancer cells
X Zhang, J Guo, PJ Kaboli, Q Zhao, S Xiang, J Shen, Y Zhao, F Du, X Wu, ...
OncoTargets and therapy 13, 7295, 2020
102020
系统目前无法执行此操作,请稍后再试。
文章 1–20